Polymyalgia rheumatica preceding small-vessel vasculitis: Changed spots or misdiagnosis?

QJM: An International Journal of Medicine

Volumn 97, Issue 5, 2004, Pages 289-292

  Little, M A ^a   Nazar, L ^a   Farrington, Ken ^a  

^a LISTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COTRIMOXAZOLE; CREATININE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE;

AGE; AGED; ANAMNESIS; ANTIBODY DETECTION; ARTICLE; BLOOD VESSEL BIOPSY; CASE CONTROL STUDY; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DIAGNOSTIC ERROR; DIALYSIS; DISEASE DURATION; ELDERLY CARE; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HEMATURIA; HUMAN; HYPOTHESIS; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PLASMAPHERESIS; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROTEINURIA; RECURRENCE RISK; RETROSPECTIVE STUDY; RHEUMATIC POLYMYALGIA; SMALL VESSEL VASCULITIS; SYMPTOM; URINALYSIS;

EID: 2442713851     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/hch055     Document Type: Article

References (14)

1. USRDS annual report: Survival, mortality, and causes of death. Am J Kidney Dis 2003; 41(Suppl.):S151-64.
2. Aasarod K, Iversen BM, Hammerstrom J, Bostad L, Vatten L, Jorstad S. Wegener's granulomatosis: clinical course in 108 patients with renal involvement. Nephrol Dial Transplant 2000; 15:611-18.
3. Aasarod K, Bostad L, Hammerstrom J, Jorstad S, Iversen BM. Renal histopathology and clinical course in 94 patients with Wegener's granulomatosis. Nephrol Dial Transplant 2001; 16:953-60.
4. Guillevin L, Cordier JF, Lhote F, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum 1997; 40:2187-98.
5. Adu D, Pall A, Luqmani RA, Richards NT, Howie AJ, Emery P, Michael J, Savage CO, Bacon PA. Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. Q J Med 1997; 90:401-9.
6. Allen A, Pusey C, Gaskin G. Outcome of renal replacement therapy in antineutrophil cytoplasmic anti body-associated systemic vasculitis. J Am Soc Nephrol 1998; 9:1258-63.
7. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988; 318:1651-7.
8. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98:76-85.
9. Haroun MK SJ, Nair R, Racusen L, Hellmann DB, Eustace JA. Correlation of percentage of normal glomeruli with renal outcome in Wegener's granulomatosis. Am J Nephrol 2002; 22:497-503.
10. Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's Granulomatosis Classification Criteria Cohort. Am J Med 1996; 101:129-34.
11. Aasarod K, Iversen BM, Hammerstrom J, Bostad L, Jorstad S. Clinical outcome of patients with Wegener's granulomatosis treated with plasma exchange. Blood Purif 2002; 20:167-73.
12. Boomsma MM, Stegeman CA, van der Leij MJ, Oost W, Hermans J, Kallenberg CG, Limburg PC, Cohen Tervaert JW. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum 2000; 43:2025-33.
13. Savage CO. ANCA-associated renal vasculitis. Kidney Int 2001; 60:1614-27.
14. Weyand CM, Goronzy JJ. Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med 2003; 139:505-15.